Thewjitcharoen, Y., Karndumri, K., Chatchomchuan, W., Porramatikul, S., Krittiyawong, S., Wanothayaroj, E., . . . Himathongkam, T. (2020). Serum T3 Level and Duration of Minimum Maintenance Dose Therapy Predict Relapse in Methimazole-Treated Graves Disease. J Endocr Soc.
Chicago Stili AlıntıThewjitcharoen, Yotsapon, et al. "Serum T3 Level and Duration of Minimum Maintenance Dose Therapy Predict Relapse in Methimazole-Treated Graves Disease." J Endocr Soc 2020.
MLA AlıntıThewjitcharoen, Yotsapon, et al. "Serum T3 Level and Duration of Minimum Maintenance Dose Therapy Predict Relapse in Methimazole-Treated Graves Disease." J Endocr Soc 2020.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..